Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2
NCT00383604 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2013-05-30
Summary
To better understand the mechanisms leading to lymphedema development in breast cancer survivors, and the implications for potential innovative approaches to the screening, prevention and treatment of this condition.
Conditions
- Lymphedema
- Breast Cancer
Sponsors & Collaborators
-
California Breast Cancer Research Program
collaborator OTHER - lead OTHER
Principal Investigators
-
Stanley G Rockson · Stanford University
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-07-31
- Primary Completion
- 2012-03-31
- Completion
- 2012-04-30
Countries
- United States
Study Locations
More Related Trials
-
Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema
NCT02734979 ·Status: COMPLETED ·Phase: NA
-
Intensive Education in Increasing Understanding of Lymphedema in Patients With Breast Cancer Undergoing Surgery
NCT02073045 ·Status: TERMINATED ·Phase: NA
-
Self-Care for Lymphedema in Patients With Breast Cancer
NCT00670644 ·Status: COMPLETED
-
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
NCT06144164 ·Status: RECRUITING ·Phase: PHASE3
-
Pre-existing Factors, Early Detection and Early Treatment of Breast Cancer Related Lymphedema
NCT03210311 ·Status: COMPLETED ·Phase: NA
-
Predictors of Lymphedema Following Breast Cancer Surgery
NCT00202046 ·Status: COMPLETED
-
Effectiveness of CDT for the Treatment of Lymphedema in Breast Cancer Patients Who Received LVA Surgery
NCT06569719 ·Status: COMPLETED ·Phase: NA
-
Body Awareness and Functionality in Lymphedema
NCT06036173 ·Status: COMPLETED
-
Supermicrosurgical Lymphaticovenous Anastomosis for Prevention of Upper Limb Lymphedema
NCT07026292 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Bioelectrical Impedance Utilization and Dietary Intake Relation in the Breast Cancer Related Lymphedema
NCT03391206 ·Status: COMPLETED
-
Who and Why do Patients Report Lymphedema After Breast Cancer Treatment Without an Objective Measurable Swelling
NCT06324721 ·Status: RECRUITING ·Phase: NA
-
LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
NCT05366699 ·Status: RECRUITING ·Phase: NA
-
Treatment of Breast Cancer-related Lymphedema With a Negative Pressure Device
NCT03252145 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Acupuncture for Breast Cancer Related Lymphedema
NCT02803736 ·Status: UNKNOWN ·Phase: NA
-
Lymphedema Surveillance Study
NCT02743858 ·Status: RECRUITING
-
Single-Photon Emission Computed Tomography, Computed Tomography Lymphoscintigraphy, and Intensity-Modulated Radiation Therapy in Treating Patients Who Have Undergone Surgery for Stage I or Stage II Breast Cancer
NCT00743314 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Early Detection and Intervention for Mild and Moderate Lymphedema in Patients Treated for Breast Cancer
NCT00959985 ·Status: TERMINATED ·Phase: NA
-
Biomarkers of Fatigue Related to Adjuvant Chemotherapy for Breast Cancer
NCT02041364 ·Status: UNKNOWN
-
PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema
NCT05056207 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Prospective Observational Study of Lymphedema in Breast Cancer With Axillary Lymph Node Dissection
NCT01969253 ·Status: COMPLETED
-
Morbidity Following the Diagnosis and Treatment of Patients With Breast Cancer
NCT00027105 ·Status: COMPLETED
-
Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.
NCT01276054 ·Status: TERMINATED ·Phase: PHASE2
-
PRELUDE Study of Lymphatic Surgery to Treat Breast Cancer Related Lymphoedema
NCT04579029 ·Status: UNKNOWN ·Phase: NA
-
Fat Grafting Used for the Treatment of Breast Cancer Related Lymphedema in China
NCT02981485 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Breast Cancer Related Lymphedema With Cell-assisted Lipotransfer
NCT02592213 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2